Cargando…

Tobacco Use in Bipolar Disorder

Tobacco use in mental health in general and bipolar disorder in particular remains disproportionally common, despite declining smoking rates in the community. Furthermore, interactions between tobacco use and mental health have been shown, indicating the outcomes for those with mental health disorde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomson, Daniel, Berk, Michael, Dodd, Seetal, Rapado-Castro, Marta, Quirk, Shae E., Ellegaard, Pernille K., Berk, Lesley, Dean, Olivia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423166/ https://www.ncbi.nlm.nih.gov/pubmed/25912533 http://dx.doi.org/10.9758/cpn.2015.13.1.1

Ejemplares similares

Evaluation of the acceptability and usefulness of an information website for caregivers of people with bipolar disorder
por: Berk, Lesley, et al.
Publicado: (2013)

Evaluating discussion board engagement in the MoodSwings online self-help program for bipolar disorder: protocol for an observational prospective cohort study
por: Gliddon, Emma, et al.
Publicado: (2015)

Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder
por: Kim, Sung-Wan, et al.
Publicado: (2015)

N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
por: Arancini, Lauren, et al.
Publicado: (2019)

Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
por: Dodd, Seetal, et al.
Publicado: (2015)

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice
por: Kulkarni, Jayashri, et al.
Publicado: (2012)

Effect of Glucocorticoid and 11β-Hydroxysteroid-Dehydrogenase Type 1 (11β-HSD1) in Neurological and Psychiatric Disorders
por: Dodd, Seetal, et al.
Publicado: (2022)

Falls in community-dwelling women with bipolar disorder: a case–control study
por: Stuart, Amanda L., et al.
Publicado: (2022)

A brief review of exercise, bipolar disorder, and mechanistic pathways
por: Thomson, Daniel, et al.
Publicado: (2015)

Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
por: Salagre, Estela, et al.
Publicado: (2018)

Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression?
por: Russell, Samantha E., et al.
Publicado: (2023)

Mitochondrial Agents for Bipolar Disorder
por: Pereira, Círia, et al.
Publicado: (2018)

Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression
por: Russell, Samantha E., et al.
Publicado: (2022)

Online ethics: where will the interface of mental health and the internet lead us?
por: Cosgrove, Victoria, et al.
Publicado: (2017)

Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
por: Ellegaard, Pernille Kempel, et al.
Publicado: (2018)

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
por: Berk, Michael, et al.
Publicado: (2012)

The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia
por: Ashton, Melanie M., et al.
Publicado: (2019)

Staging in bipolar disorder: one step closer to precision psychiatry
por: Fernandes, Brisa S., et al.
Publicado: (2017)

The role of lamotrigine in the management of bipolar disorder
por: Ng, Felicity, et al.
Publicado: (2007)

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

A shared framework for the common mental disorders and Non-Communicable Disease: key considerations for disease prevention and control
por: O’Neil, Adrienne, et al.
Publicado: (2015)

Correction: A shared framework for the common mental disorders and Non-Communicable Disease: key considerations for disease prevention and control
por: O’Neil, Adrienne, et al.
Publicado: (2022)

Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review
por: Ashton, Melanie M, et al.
Publicado: (2019)

Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia
por: Ghanizadeh, Ahmad, et al.
Publicado: (2013)

The Impact of Posttraumatic Stress Disorder on Pharmacologic Intervention Outcomes for Adults With Bipolar Disorder: A Systematic Review
por: Russell, Samantha E, et al.
Publicado: (2022)

Influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder: protocol for a systematic review and meta-analysis
por: Wrobel, Anna, et al.
Publicado: (2021)

Tobacco smoking predicts depression and poorer quality of life in heart disease
por: Stafford, Lesley, et al.
Publicado: (2013)

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
por: Sethi, Rickinder, et al.
Publicado: (2019)

The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment
por: Giménez-Palomo, Anna, et al.
Publicado: (2021)

Cost-Utility and Cost-effectiveness of MoodSwings 2.0, an Internet-Based Self-management Program for Bipolar Disorder: Economic Evaluation Alongside a Randomized Controlled Trial
por: Chatterton, Mary Lou, et al.
Publicado: (2022)

SLC6A4 STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study
por: Pizzo de Castro, Márcia Regina, et al.
Publicado: (2014)

Listening to the silent struggles of bipolar disorder through sonification of iMoodJournal data
por: Angeler, David G., et al.
Publicado: (2022)

Harnessing the potential of community-based participatory research approaches in bipolar disorder
por: Michalak, Erin E., et al.
Publicado: (2016)

Personality Disorder and Physical Health Comorbidities: A Link With Bone Health?
por: Williams, Lana J., et al.
Publicado: (2020)

The mental health and lifestyle impacts of COVID-19 on bipolar disorder
por: Karantonis, James A., et al.
Publicado: (2021)

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial
por: Dean, Olivia May, et al.
Publicado: (2014)

Bipolar At-Risk Criteria and Risk of Bipolar Disorder Over 10 or More Years
por: Ratheesh, Aswin, et al.
Publicado: (2023)

Web-based intervention to improve quality of life in late stage bipolar disorder (ORBIT): randomised controlled trial protocol
por: Fletcher, Kathryn, et al.
Publicado: (2018)

Transcriptional Modulation of the Hippo Signaling Pathway by Drugs Used to Treat Bipolar Disorder and Schizophrenia
por: Panizzutti, Bruna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ksts6455ug3h7hu90k14o6dhib